Citigroup Inc Biond Vax Pharmaceuticals Ltd. Transaction History

Citigroup Inc

  • $153 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$1.16 - $1.88 $2,320 - $3,760
-2,000 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$1.15 - $2.34 $2,300 - $4,680
2,000 New
2,000 $3,000

About BiondVax Pharmaceuticals Ltd.

BVXV Quotes by TradingView
  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email